Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 12
Submit an article Journal homepage
1,854
Views
15
CrossRef citations to date
0
Altmetric
Review

Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD)

Giulio PerugiDepartment of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa, Pisa, ItalyCorrespondence[email protected]
View further author information
,
Alessandro PallucchiniDepartment of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa, Pisa, ItalyView further author information
,
Salvatore RizzatoPsychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, ItalyView further author information
,
Vito PinzonePsychiatry Residency Training Program, Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, ItalyView further author information
&
Pietro De RossiNESMOS Department (Neurosciences, Mental Health, and Sensory Organs), Sapienza University of Rome, School of Medicine and Psychology, Sant’Andrea Hospital, Rome, Italy;Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy;Department of Psychiatry, ASL Roma 5, Rome, ItalyView further author information
Pages 1457-1470 | Received 22 Jan 2019, Accepted 09 May 2019, Published online: 21 May 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell’Osso & Carla Carnovale. (2023) Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert Review of Clinical Pharmacology 16:5, pages 453-465.
Read now
Chen Chen, Si Dai, Lijuan Shi, Yidong Shen & Jianjun Ou. (2021) Associations Between Attention Deficit/Hyperactivity Disorder and Internet Gaming Disorder Symptoms Mediated by Depressive Symptoms and Hopelessness Among College Students. Neuropsychiatric Disease and Treatment 17, pages 2775-2782.
Read now

Articles from other publishers (13)

Margherita Barbuti, Marco Maiello, Vincenza Spera, Alessandro Pallucchini, Giulio E. Brancati, Angelo G. I. Maremmani, Giulio Perugi & Icro Maremmani. (2023) Challenges of Treating ADHD with Comorbid Substance Use Disorder: Considerations for the Clinician. Journal of Clinical Medicine 12:9, pages 3096.
Crossref
Mohamed Hassan Elnaem, Merna Mahmoud AbouKhatwa, Mahmoud E. Elrggal & Inderpal Singh Dehele. (2023) Attention Deficit Hyperactivity Disorder: What Are Pharmacists’ Roles and Associated Outcomes?. International Journal of Environmental Research and Public Health 20:3, pages 2754.
Crossref
Stephen V. FaraoneAnn C. Childress, Roberto GomeniEman RaflaJudith C. KandoLori DansiePayal Naik & Antonio Pardo. (2023) Efficacy of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder: Effect Size Across the Day. Journal of Child and Adolescent Psychopharmacology 33:1, pages 14-19.
Crossref
Jeff Schein, Ann Childress, Martin Cloutier, Urvi Desai, Andi Chin, Mark Simes, Annie Guerin & Julie Adams. (2022) Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review study. BMC Psychiatry 22:1.
Crossref
Anna Comparelli, Lorenzo Polidori, Giuseppe Sarli, Andrea Pistollato & Maurizio Pompili. (2022) Differentiation and comorbidity of bipolar disorder and attention deficit and hyperactivity disorder in children, adolescents, and adults: A clinical and nosological perspective. Frontiers in Psychiatry 13.
Crossref
Hannah W Haddad, Paul B. Hankey, Jimin Ko, Zahaan Eswani, Pravjit Bhatti, Amber N. Edinoff, Adam M. Kaye & Alan D. Kaye. (2022) Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update. Health Psychology Research 10:2.
Crossref
Wendy Verónica Herrera-Morales, Leticia Ramírez-Lugo, Roger Cauich-Kumul, Eric Murillo-Rodríguez & Luis Núñez-Jaramillo. (2022) Personalization of Pharmacological Treatments for ADHD: Why it is Advisable and Possible Options to Achieve it. Current Topics in Medicinal Chemistry 22:15, pages 1236-1249.
Crossref
Angelo G. I. Maremmani, Pasqualina Rocco, Filippo Della Rocca, Giulio Perugi, Mario Miccoli & Icro Maremmani. (2021) Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up. International Journal of Environmental Research and Public Health 18:20, pages 10997.
Crossref
Giulio Perugi & Margherita Barbuti. (2021) There are no patients without comorbidity. European Neuropsychopharmacology 50, pages 104-106.
Crossref
Tara T. Lineweaver, Suneeta Kercood, Alexandra J. Gabor, Jhovana Cervantes, Abigail Laine & Ellen Baker. (2021) The effect of medication and question wording on self‐reported symptoms and their accuracy in young adults with attention‐deficit/hyperactivity disorder. British Journal of Clinical Psychology 60:2, pages 252-269.
Crossref
Luis Núñez-Jaramillo, Andrea Herrera-Solís & Wendy Verónica Herrera-Morales. (2021) ADHD: Reviewing the Causes and Evaluating Solutions. Journal of Personalized Medicine 11:3, pages 166.
Crossref
Kentaro Kawabe, Fumie Horiuchi, Kiwamu Nakachi, Rie Hosokawa & Shu-ichi Ueno. (2020) Clinical Assessment for Attention Test in adult with Attention-Deficit/Hyperactivity Disorder for Evaluation of symptoms and medication effects. Clinical Neuropsychopharmacology and Therapeutics 11:0, pages 35-42.
Crossref
Gianmaria Zita & Giovanni Migliarese. (2020) La doppia diagnosi ADHD e SUD. MISSION:53, pages 10-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.